Memorial Şişli Hospital
Dilek Necioglu Orken



Save up to
88%
vs. average UK or US prices
Last updated: 11/13/2026

Medically reviewed by
Fahad Mawlood
Medical Disclaimer: Data verified by Bookimed as of November 2026, based on patient requests and official quotes from 38 clinics worldwide. Median costs are based on real invoices (2024–2026) and updated monthly. Actual prices may vary.
Turkey provides specialized multiple sclerosis care featuring neurologists trained at global centers like MD Anderson. Patients choose Istanbul for its high-resolution 3 Tesla MRI diagnostics and JCI-accredited clinics. These centers monitor infusions using targeted immune protocols to manage B-cell activity while protecting normal immune function.
Bookimed Expert Insight: Turkey's leading neurology departments often concentrate in Istanbul. This allows patients to access specialists like Dr. Baris Topcular, who trained at the University of Basel. This specific international training ensures patients receive precise molecular neuroimaging often required before starting infusions.
What patients say: Patients note that access to this treatment depends largely on insurance policy changes within Turkey. They often use community petitions and manufacturer programs to ensure their therapy stays on track. Many find the structured infusion schedules in Istanbul hospitals very convenient for international travel.



Spain offers high-standard neurological care for multiple sclerosis through specialized centers like Hospital Ruber Internacional. The country provides Ocrevus for both relapsing and primary progressive MS. Expert neurologists use intravenous protocols to slow disability progression. Patients benefit from biannual infusion schedules in internationally accredited facilities.
Bookimed Expert Insight: Spain's neurology network is highly concentrated, with top experts like Dr. Anna Pujol in Barcelona and Dr. Jose Angel Obeso in Madrid. These specialists often work within large private hospital groups like Quirónsalud. This allows patients to access integrated care, including physical therapy and neurorehabilitation, at the same location as their infusions.
What patients say: Patients appreciate the biannual infusion schedule because it allows for a more flexible lifestyle. Many note that preparing administrative records and recent imaging is essential for starting care in Spain. Coordination between neurologists and hospital pharmacies ensures consistent access to the medication.






Patients choose Mexico for Ocrevus treatment to improve access to anti-CD20 therapy for multiple sclerosis. Border clinics offer convenient reach for North American patients seeking specialized infusion services. Mexican centers follow rigorous protocols. These include pre-infusion screenings like hepatitis B testing to ensure patient safety.
Bookimed Expert Insight: Mexican clinics often serve as a bridge for patients deciding between biologics and HSCT. Specialists in Mexico City or Monterrey often provide personalized plans for both. This allows patients to access high-efficacy therapies like Ocrevus while consulting on long-term MS management.
What patients say: Mexico is often discussed as a key hub for managing multiple sclerosis symptoms. Patients note the twice-yearly Ocrevus schedule is convenient for those traveling from abroad. They value the six-hour infusion sessions as a safer alternative to more intensive procedures.
Germany provides rapid access to Ocrevus for both relapsing and primary progressive multiple sclerosis. Specialist centers use a twice-yearly dosing schedule to manage disease progression effectively. Patients benefit from neurologists who lead international research societies and utilize university-affiliated protocols for high-precision treatment administration.
Bookimed Expert Insight: German clinics often provide Ocrevus via infusion and now offer 10-minute subcutaneous options. This flexibility allows patients to spend less time in the hospital during their visits. Leading centers in Frankfurt operate with 28 specialized departments to manage all MS-related symptoms.
What patients say: Patients note the staff expertise and well-organized nature of treatment in Germany. They appreciate the professionalism of the medical teams and the high level of comfort provided. Many feel confident because the doctors possess deep knowledge of the latest MS protocols.




Transparent methodology - so you can trust our recommendations.
Whether you're looking for the cheapest place to get ocrevus (ocrelizumab) or the highest-rated specialists abroad, Bookimed's ranking accounts for everything that matters. It uses a smart algorithm that continuously analyzes real-world data from verified verified clinics worldwide, including:
435 patient requests
We analyze thousands of real cases to identify destinations with the highest patient demand and best outcomes for ocrevus (ocrelizumab).
4 verified patient reviews
Real feedback on hospital facilities, staff communication, recovery experience, and long-term results.
Accreditation standards
International accreditations such as JCI and ISO 9001, or equivalent national certifications, verified annually.
Board-certified specialists
Evaluated by credentials, volume of successful cases for ocrevus (ocrelizumab), and specialized training.
Transparent price data
Aggregated directly from clinics and cross-checked against other ranking criteria - so the cheapest countries for ocrevus (ocrelizumab) on our list are also among the safest.
Medical excellence & innovation
We prioritize countries using the latest techniques and equipment for ocrevus (ocrelizumab), with proven track records in international patient care.
Choosing a country for Ocrevus (ocrelizumab) abroad shouldn't come down to guesswork. With more than 1,000,000 patient inquiries since 2014, we know which destinations combine the best specialists, safest hospitals, and affordable prices. We're here to help you find the right one.

Anna Leonova
Ocrevus (ocrelizumab) is an innovative drug for the treatment of multiple sclerosis. This is a monoclonal antibody. It is programmed to search for and destroy cells that contribute to the development of multiple sclerosis.
Ocrevus is the first and only drug to date that fights the primary progressive form of multiple sclerosis.
Ocrelizumab reverses the course of the disease and slows its progression. During clinical trials of Ocrevus, doctors recorded a significant decrease in lesions in the brain on MRI images of patients. The drug was approved under an accelerated scheme due to its effectiveness.
Ocrelizumab is often given by injection for the treatment of multiple sclerosis. 1 dose of the drug - 300 mg. At the beginning of treatment, the patient may receive 1 injection, after 2 weeks - another one. Repeated procedures should be carried out every six months.
Today I feel very good. I have been on Ocrevus for about 4 months and the effect is huge. I am delighted! Happy for the people it helps. You know there's a saying, "Don't believe what you hear, believe what you see" - I can lift 25 pounds. I'm stronger, really stronger.
Patient review taken from Youtube